Androsterone

Androsterone

SCHEMBL17165674

C[C@]12CC[C@@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12.C[C@]12CC[C@H](O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C(=O)CC[C@@H]12.O=S(=O)(O)O.O=S(=O)(O)O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO

The experimentally established mechanism targets of Androsterone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
G6PD P11413 6/20 0.90
GPBAR1 Q8TDU6 4/20 0.90
LMNA P02545 3/20 0.90
CYP3A4 P08684 3/20 0.90
MEN1 O00255 3/20 0.90
KMT2A Q03164 3/20 0.90
MAPK1 P28482 3/20 0.90
SHBG P04278 2/20 0.90
SERPINA6 P08185 2/20 0.90
HSD17B3 P37058 1/20 0.90
PMP22 Q01453 1/20 0.90
AKR1B10 O60218 1/20 0.90
AKR1B1 P15121 1/20 0.90
CYP2D6 P10635 1/20 0.90
TSHR P16473 1/20 0.90
NFKB1 P19838 1/20 0.90
CYP2C19 P33261 1/20 0.90
ALDH1A1 P00352 1/20 0.61
TP53 P04637 1/20 0.61
MAPT P10636 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Androsterone SCHEMBL17165679 1.00 G6PD (0.90) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL235686 1.00 G6PD (0.90) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL136325 1.00 G6PD (0.90) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL7989333 0.99 G6PD (0.88) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL1570817 0.99 G6PD (0.88) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL7996607 0.99 G6PD (0.88) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL23031469 0.95 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL19750468 0.95 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL269982 0.95 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1
Androsterone SCHEMBL15426610 0.95 G6PD (1.00) G6PDGPBAR1LMNACYP3A4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3151665-A1 METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK Laboratory Corporation of America Holdings (US) 2017-04-12 EP disclosed
WO-2015157601-A1 METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK SYNAPDX CORPORATION (US) 2015-10-15 WO disclosed